Estimating Increased EGP During Stress Response in Critically Ill Patients
Jennifer J Ormsbee1, Jennifer L Knopp1, J Geoffrey Chase1
1Department of Mechanical Engineering, Centre for Bioengineering, University of Canterbury, Christchurch, New Zealand.
Journal of Diabetes Science and Technology
|June 2, 2020
Summary
Critically ill patients with stress hyperglycemia benefit from glycemic control (GC). This study shows a population EGP value is sufficient for most patients, but some need adjusted models due to extreme stress responses.
Area of Science:
- Critical Care Medicine
- Endocrinology
- Pharmacokinetics
Background:
- Stress-induced hyperglycemia is common in critically ill patients.
- Effective glycemic control (GC) improves outcomes in intensive care units (ICUs).
- Model-based GC requires accurate parameter assumptions, including endogenous glucose production (EGP).
Purpose of the Study:
- To explore endogenous glucose production (EGP) variability in critically ill patients.
- To assess the adequacy of a population-based parameter for EGP in ICU glycemic control models.
- To investigate the impact of stress response on EGP.
Main Methods:
- Hourly insulin sensitivity (SI) was calculated from clinical data of 145 ICU patients.
- Lower bounds were imposed on SI to estimate EGP during potential stress responses.
- Minimum EGP and event durations were analyzed.
Main Results:
- Constrained EGP events occurred in 1.6% of patient hours, primarily within the first 12 hours and without nutrition.
- Estimated EGP ranged from 1.16 to 2.75 mmol/min, with most below 1.5 mmol/min.
- The current population EGP value of 1.16 mmol/min was sufficient for over 98% of patient hours.
Conclusions:
- A population EGP value is generally adequate for ICU glycemic control.
- A small subset of patients exhibits significantly elevated EGP, likely due to severe early-stage stress responses.
- Further investigation into EGP variability in extreme stress is warranted.
Keywords:
EGPcritical illnessendogenous glucose productionglycemic controlhyperglycemiainsulin resistanceinsulin sensitivityphysiological stressMore Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
712
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
712
Glucose Homeostasis: Regulation of Blood Glucose
3.5K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.0K
Metabolic States of the Body: The Postabsorptive State
1.2K
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.2K
Hormones Regulating Blood Glucose
6.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.1K
Overview of Carbohydrate Metabolism
3.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.0K


